» Articles » PMID: 34272701

Principles and Experimental Considerations for In Vitro Transporter Interaction Assays

Overview
Specialty Molecular Biology
Date 2021 Jul 17
PMID 34272701
Authors
Affiliations
Soon will be listed here.
Abstract

Drug transporters are universally acknowledged as important determinants of the absorption, distribution, metabolism, and excretion of both endogenous and exogenous compounds. Altered transporter function, whether due to genetic polymorphism, DDIs, disease, or environmental factors such as dietary constituents, can result in changes in drug efficacy and/or toxicity due to changes in circulating or tissue levels of either drugs or endogenous substrates.Prediction of whether and to what extent the biological fate of a drug is influenced by drug transporters, therefore, requires in vitro test systems that can accurately predict the risk and magnitude of clinical DDIs. While these in vitro assessments appear simple in theory, practitioners recognize that there are multiple factors that can influence experimental outcomes. A better understanding of these variables, including test compound characteristics, test systems, assay formats, and experimental design, will enable clear, actionable steps and translatable outcomes that may avoid unnecessary downstream clinical engagement. This chapter will delineate the role of these variables in improving in vitro assay outcomes.

References
1.
Dresser M, Leabman M, Giacomini K . Transporters involved in the elimination of drugs in the kidney: organic anion transporters and organic cation transporters. J Pharm Sci. 2001; 90(4):397-421. DOI: 10.1002/1520-6017(200104)90:4<397::aid-jps1000>3.0.co;2-d. View

2.
Venter J, Adams M, Myers E, Li P, Mural R, Sutton G . The sequence of the human genome. Science. 2001; 291(5507):1304-51. DOI: 10.1126/science.1058040. View

3.
Koepsell H . Organic cation transporters in intestine, kidney, liver, and brain. Annu Rev Physiol. 1998; 60:243-66. DOI: 10.1146/annurev.physiol.60.1.243. View

4.
Meijer D, Hooiveld G, Schinkel A, van Montfoort J, Haas M, de Zeeuw D . Transport mechanisms for cationic drugs and proteins in kidney, liver and intestine: implication for drug interactions and cell-specific drug delivery. Nephrol Dial Transplant. 1999; 14 Suppl 4:1-3. DOI: 10.1093/ndt/14.suppl_4.1b. View

5.
Inui K, Masuda S, Saito H . Cellular and molecular aspects of drug transport in the kidney. Kidney Int. 2000; 58(3):944-58. DOI: 10.1046/j.1523-1755.2000.00251.x. View